News & Events
News / press releases
TV report on COR-101
CORAT’s CEO Dr. Andreas Herrmann and CSO Dr. André Frenzel comment in international television on the start of clinical studies with CORAT Therapeutics SARS-CoV-2 neutralising antibody COR-101 against COVID-19 in hospitalized patients. The article can be viewed at the following link: COVID-19 Special: The challenge of developing a cure Source:...
events / conferences
events 2021
link
BIO Europe 2021
October 25 – 28, 2021 | Virtual
PEGS Boston 2021
June 10 – 18, 2021 | Virtual
Biologics Europe 2021
April 25 – 28, 2021 | Virtual